These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2633080)
1. [Use of neuroleptoanesthesia for carrying out a Harrington intervention in a patient probably susceptible to malignant hyperthermia]. Lauri A; Corbari M; Galli C; Marri M Minerva Anestesiol; 1989 Sep; 55(9):331-5. PubMed ID: 2633080 [TBL] [Abstract][Full Text] [Related]
2. Anesthesia in malignant hyperthermia susceptible patients. Mauritz W; Hackl W; Winkler M; Sporn P; Steinbereithner K Acta Anaesthesiol Belg; 1990; 41(2):87-94. PubMed ID: 1973553 [TBL] [Abstract][Full Text] [Related]
3. [Malignant hyperthermia in Austria. III. Anesthesia in susceptible patients]. Mauritz W; Hackl W; Sporn P; Steinbereithner K Anaesthesist; 1988 Aug; 37(8):522-8. PubMed ID: 3177878 [TBL] [Abstract][Full Text] [Related]
4. Malignant hyperthermia and the otolaryngologist. Chang CY; Scher RL Ear Nose Throat J; 2003 Jun; 82(6):433-6. PubMed ID: 12861868 [TBL] [Abstract][Full Text] [Related]
9. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry. Litman RS; Flood CD; Kaplan RF; Kim YL; Tobin JR Anesthesiology; 2008 Nov; 109(5):825-9. PubMed ID: 18946294 [TBL] [Abstract][Full Text] [Related]
10. [Living with the diagnosis of malignant hyperthermia]. Kato A Masui; 2002 Nov; 51(11):1280-4. PubMed ID: 12481461 [TBL] [Abstract][Full Text] [Related]
12. [An activated charcoal filter for eliminating volatile anesthetics. A contribution to the management of malignant hyperthermia]. Jantzen JP; Eck J; Kleemann PP Anaesthesist; 1989 Nov; 38(11):639-41. PubMed ID: 2635839 [TBL] [Abstract][Full Text] [Related]
13. The screening of propofol in MHS swine. Raff M; Harrison GG Anesth Analg; 1989 Jun; 68(6):750-1. PubMed ID: 2786680 [TBL] [Abstract][Full Text] [Related]
14. [Malignant hyperthermia; two cases of MH in the presence of general anesthesia and performing caffeine contracture test]. Tateishi M; Sumita S; Watanabe H; Kumeta H; Narimatsu E; Namiki A Masui; 1989 Apr; 38(4):546-51. PubMed ID: 2724520 [TBL] [Abstract][Full Text] [Related]
15. Malignant hyperthermia: is etomidate safe? Suresh MS; Nelson TE Anesth Analg; 1985 Apr; 64(4):420-4. PubMed ID: 3985391 [TBL] [Abstract][Full Text] [Related]
16. ["Malignant hyperthermia" following NLA and spinal anaesthesia (author's transl)]. Malz H; Gullotta F; Klein H; Aebert K Anaesthesist; 1982 May; 31(5):248-51. PubMed ID: 7103033 [TBL] [Abstract][Full Text] [Related]
17. Malignant hyperthermia-triggering liability of selected inhalant anesthetics in swine. McGrath CJ; Rempel WE; Jessen CR; Addis PB; Crimi AJ Am J Vet Res; 1981 Apr; 42(4):604-7. PubMed ID: 7332119 [TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of disposition for malignant hyperthermia--an updated review based on 1,001 studies]. Olthoff D; Deutrich C; Meinecke CD Anaesthesiol Reanim; 1997; 22(2):32-40. PubMed ID: 9235003 [TBL] [Abstract][Full Text] [Related]
19. [Anesthesiologic management of susceptible children at risk for malignant hyperthermia]. Ferrari F; D'Alessandro S; Pietrandrea G; Villani A Minerva Anestesiol; 1997 Oct; 63(10):311-4. PubMed ID: 9567608 [TBL] [Abstract][Full Text] [Related]